Some phenolic natural compounds as carbonic anhydrase inhibitors: An in vitro and in silico study
| dc.contributor.author | Aggul, Ahmet Gokhan | |
| dc.contributor.author | Uzun, Naim | |
| dc.contributor.author | Kuzu, Muslum | |
| dc.contributor.author | Taslimi, Parham | |
| dc.contributor.author | Gülçin, İlhami | |
| dc.contributor.author | Taslimi, Parham | |
| dc.date.accessioned | 2025-10-18T13:23:12Z | |
| dc.date.created | 2022 | |
| dc.date.issued | 2022 | |
| dc.department | Fakülteler, Fen Fakültesi, Biyoteknoloji Bölümü | |
| dc.description.abstract | This paper presents experimental and molecular docking studies on the inhibitory effects of tyrosol, hydroxytyrosol, luteolin, diosmetin, caffeic acid, luteolin 7-O-glycoside, and apigenin 7-O-glycoside from olive (Olea europaea L.) leaf against human carbonic anhydrase (hCA, E.C.4.2.1.1) isozymes I and II. After these isozymes were separately purified, their activities were determined using the esterase activity. IC50 values for hCA I and II were calculated as 2.02-11.38 mu M and 2.23-9.05 mu M, respectively. The compounds were identified as CA inhibitors, with K-i values in the ranges of 1.66-9.17 mu M for the hCA I isozyme and 1.49-14.21 mu M for hCA II. The inhibitory effects of these natural compounds were also compared to acetazolamide, which is a potent inhibitor of both CA isozymes. Our results may contribute to the synthesis of new CA inhibitors and pave the way for new drug design in the treatment of a number of diseases including cancer, obesity, diabetes, and glaucoma. | |
| dc.identifier.doi | 10.1002/ardp.202100476 | |
| dc.identifier.issn | 0365-6233 | |
| dc.identifier.issn | 1521-4184 | |
| dc.identifier.issue | 6 | |
| dc.identifier.orcid | Taslimi, Parham/0000-0002-3171-0633 | |
| dc.identifier.orcid | AGGUL, AHMET GOKHAN/0000-0003-0377-0388 | |
| dc.identifier.orcid | Gulcin, ilhami/0000-0001-5993-1668 | |
| dc.identifier.orcid | KUZU, Muslum/0000-0002-1375-7673 | |
| dc.identifier.orcid | UZUN, NAIM/0000-0002-9763-7643 | |
| dc.identifier.pmid | 35306678 | |
| dc.identifier.scopus | 2-s2.0-85126563829 | |
| dc.identifier.scopusquality | Q1 | |
| dc.identifier.uri | https://doi.org/10.1002/ardp.202100476 | |
| dc.identifier.uri | https://hdl.handle.net/11772/22743 | |
| dc.identifier.volume | 355 | |
| dc.identifier.wos | WOS:000770784600001 | |
| dc.identifier.wosquality | Q1 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | |
| dc.publisher | Wiley-V C H Verlag Gmbh | |
| dc.relation.ispartof | Archiv Der Pharmazie | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.relation.sdg | Goal-03: Good Health and Well-Being | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.snmz | WoS_20251016 | |
| dc.subject | Carbonic Anhydrase | |
| dc.subject | Enzyme Inhibition | |
| dc.subject | Molecular Docking | |
| dc.subject | Olive Leaf | |
| dc.subject | Phenolic Compound | |
| dc.title | Some phenolic natural compounds as carbonic anhydrase inhibitors: An in vitro and in silico study | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| relation.isAuthorOfPublication | dadfa319-65b8-4543-92b4-bea49e0139e9 | |
| relation.isAuthorOfPublication.latestForDiscovery | dadfa319-65b8-4543-92b4-bea49e0139e9 |










